YamRight

Tag: pharmaceutical policy

Behavioral Economics: Why Patients Choose Expensive Drugs Over Cheaper Alternatives

16

June

Behavioral Economics: Why Patients Choose Expensive Drugs Over Cheaper Alternatives

  • Categories: Health & Medicine
  • Comments: 14

Discover why patients choose expensive drugs over generics using behavioral economics. Learn how cognitive biases like loss aversion affect medication adherence and find practical nudges to improve health outcomes.

Recent posts

  • Cmax and AUC in Bioequivalence: What Peak Concentration and Total Exposure Really Mean 9 Dec 2025

    Cmax and AUC in Bioequivalence: What Peak Concentration and Total Exposure Really Mean

  • Gut Microbiome and Autoimmunity: How Gut Bacteria Influence Autoimmune Diseases 29 Dec 2025

    Gut Microbiome and Autoimmunity: How Gut Bacteria Influence Autoimmune Diseases

  • 180-Day Exclusivity and Authorized Generics: Legal Considerations for Drug Makers 2 Jul 2026

    180-Day Exclusivity and Authorized Generics: Legal Considerations for Drug Makers

  • Alzheimer’s Disease: Memory Loss, Progression Stages, and 2026 Treatments 9 May 2026

    Alzheimer’s Disease: Memory Loss, Progression Stages, and 2026 Treatments

  • Tendonitis in Seniors: Causes, Symptoms & Effective Treatments 29 Sep 2025

    Tendonitis in Seniors: Causes, Symptoms & Effective Treatments

Categories

  • Health & Medicine (202)

Popular tags

drug interactions medication safety generic drugs medication adherence side effects online pharmacy major depressive disorder affordable antibiotics medication errors generic medications autoimmune disease GoodRx coupons sildenafil gabapentin treatment affordable antidepressant dosing food-drug interactions SSRI side effects NSAIDs
YamRight
  • About
  • Terms
  • Privacy
  • GDPR Notice
  • Contact

© 2026. All rights reserved.